HomeSTOK • NASDAQ
add
Stoke Therapeutics Inc
Previous close
$11.69
Day range
$11.49 - $12.43
Year range
$3.35 - $16.40
Market cap
646.78M USD
Avg Volume
2.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 2.80M | -14.26% |
Operating expense | 32.39M | 6.39% |
Net income | -26.96M | -5.08% |
Net profit margin | -962.10 | -22.55% |
Earnings per share | -0.60 | 7.69% |
EBITDA | -28.96M | -9.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 201.39M | -12.28% |
Total assets | 228.34M | -10.83% |
Total liabilities | 68.78M | -3.43% |
Total equity | 159.56M | — |
Shares outstanding | 46.30M | — |
Price to book | 3.37 | — |
Return on assets | -31.59% | — |
Return on capital | -43.16% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -26.96M | -5.08% |
Cash from operations | -20.65M | 7.71% |
Cash from investing | 14.77M | -34.32% |
Cash from financing | 7.34M | 16,976.74% |
Net change in cash | 1.46M | 815.62% |
Free cash flow | -4.63M | 53.58% |
About
Founded
2014
Headquarters
Website
Employees
110